BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9121219)

  • 41. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy].
    Kobusiak-Prokopowicz M; Mysiak A
    Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction.
    Cruden NL; Graham C; Harding SA; Ludlam CA; Fox KA; Newby DE
    Thromb Res; 2006; 118(2):189-97. PubMed ID: 16055173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pulmonary hemorrhage after thrombolysis in acute myocardial infarct].
    Rodríguez Blanco VM; Barriales Alvarez V; Morís de la Tassa C
    An Med Interna; 1997 Apr; 14(4):209. PubMed ID: 9181820
    [No Abstract]   [Full Text] [Related]  

  • 45. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
    Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II project.
    Huynh T; Cox JL; Massel D; Davies C; Hilbe J; Warnica W; Daly PA;
    Am Heart J; 2004 Jul; 148(1):86-91. PubMed ID: 15215796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The adult respiratory distress syndrome as a complication of the APSAC treatment of acute myocardial infarct. Apropos a case].
    García González MJ; Bosa Ojeda F; Barragán Acea A; Marrero Rodríguez F; Laynez Cerdeña I; Lara Padrón A; Lacalzada Almeida J; de Armas Trujillo D
    Rev Esp Cardiol; 1993 Oct; 46(10):674-6. PubMed ID: 8235004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemorrhagic upper extremity complications from tissue plasminogen activator.
    Crick KA; Crick JC; Pulley MT
    J Surg Orthop Adv; 2007; 16(1):27-30. PubMed ID: 17371644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Early intravenous thrombolysis with recombinant tissue plasminogen activator for acute cerebral infarction].
    Wang SY; Wang XL; Zeng H; Zuo Y; Hu N; Li XY; Huang F; Yu HL; Wang HY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):542-5. PubMed ID: 12971850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Embolic cerebral infarction and gastrointestinal hemorrhage following thrombolytic therapy for acute myocardial infarction.
    Chang MC; Lee AY; Chang WF; Chen TJ
    Echocardiography; 2002 Feb; 19(2):139-41. PubMed ID: 11926976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thrombolytic therapy for acute ischemic stroke.
    Kelley RE
    J La State Med Soc; 2000 May; 152(5):253-8. PubMed ID: 10875215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retro-orbital hemorrhage after thrombolysis for acute myocardial infarction.
    Cunneen TS; Morlet N
    N Engl J Med; 2007 Oct; 357(14):1448-9. PubMed ID: 17914052
    [No Abstract]   [Full Text] [Related]  

  • 53. Postoperative orbital hemorrhage following thrombolysis for acute myocardial infarction.
    Yuen VH; Dolman PJ
    Can J Ophthalmol; 1999 Feb; 34(1):33-5. PubMed ID: 10088061
    [No Abstract]   [Full Text] [Related]  

  • 54. Lingual haematoma after treatment with alteplase (recombinant tissue plasminogen activator) for acute myocardial infarction.
    McMechan SR; Morrow B; Campbell NP
    Br Heart J; 1995 Aug; 74(2):205. PubMed ID: 7547005
    [No Abstract]   [Full Text] [Related]  

  • 55. Spinal epidural hematoma following coronary thrombolysis with tissue plasminogen activator. Report of two cases.
    Sawin PD; Traynelis VC; Follett KA
    J Neurosurg; 1995 Aug; 83(2):350-3. PubMed ID: 7616284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mental Dullness after thrombolytic therapy.
    Woo KS; Chan HC; Poon WS
    Postgrad Med J; 1997 Jun; 73(860):347-9. PubMed ID: 9246336
    [No Abstract]   [Full Text] [Related]  

  • 57. Diffuse alveolar hemorrhage following thrombolytic therapy for acute myocardial infarction.
    Yigla M; Sprecher E; Azzam Z; Guralnik L; Kapeliovich M; Krivoy N
    Respiration; 2000; 67(4):445-8. PubMed ID: 10940802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Side effects of thrombolytic therapy in patients with myocardial infarction].
    Agostoni A; Gardinali M
    Cardiologia; 1995 Dec; 40(12):899-908. PubMed ID: 8901040
    [No Abstract]   [Full Text] [Related]  

  • 59. Renal angiomyolipoma presenting as a retroperitoneal mass following thrombolytic therapy for acute myocardial infarction.
    Kaplan SA; Kohn I; Amis ES; O'Toole KM; Bixon R; Giella J
    N Y State J Med; 1992 May; 92(5):217-9. PubMed ID: 1614675
    [No Abstract]   [Full Text] [Related]  

  • 60. Fatal hemorrhage after recombinant tissue plasminogen activator therapy for hepatic veno-occlusive disease complicating autologous BMT.
    Otheo de Tejada E; Maldonado MS; Camarero C; Muñoz A
    Bone Marrow Transplant; 1994 Jul; 14(1):176-7. PubMed ID: 7951113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.